NDT Plus Advance Access originally published online on March 27, 2008
NDT Plus 2008 1(3):164-166; doi:10.1093/ndtplus/sfn023
| ||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Alloimmune haemolysis in a renal transplant recipient receiving sirolimus
1 Department of Nephrology
2 Department of Haematology, Royal Melbourne Hospital, Victoria, 3050 Australia
Correspondence: Shaun Flint, Department of Nephrology, Royal Melbourne Hospital, Victoria 3050, Australia. E-mail: shaun.flint@mh.org.au
Key Words: anti-ABO antibodies haemolytic anaemia passenger lymphocyte syndrome renal transplantation
Received for publication December 16, 2007. Accepted for publication February 13, 2008.
| The first 10% of the full text of this article appears below. |
| Background |
|---|
Anaemia commonly occurs following renal transplantation related to surgical blood loss, myelosuppression from immunosuppressive agents, antimicrobial prophylaxis and persisting renal impairment. A rare cause of anaemia after solid organ transplantation is alloimmune haemolysis due to antibodies from donor-derived lymphocytes accompanying the donor organ. We report the case of a 27-year-old patient receiving sirolimus who developed alloimmune haemolysis related to passenger lymphocytes. Although this has previously been reported in renal transplant recipients receiving a variety of immunosuppressive agents [11], to our knowledge this is the first case described in a patient receiving sirolimus.
| Case |
|---|
A 27-year-old male received a renal transplant from his father after 2 years on maintenance haemodialysis for end-stage renal failure due
| Discussion |
|---|
| Conclusion |
|---|